|
NZ221306A
(en)
|
1986-08-15 |
1990-02-26 |
Commw Scient Ind Res Org |
2-component immunoadjuvant comprising a mycobacterial free immunoadjuvant oil and a polycationic polyelectrolyte immunoadjuvant and vaccines thereof
|
|
EP0273512B1
(en)
|
1986-12-19 |
1991-02-27 |
Duphar International Research B.V |
Stabilised adjuvant suspension comprising dimethyl dioctadecyl ammonium bromide
|
|
US5057540A
(en)
|
1987-05-29 |
1991-10-15 |
Cambridge Biotech Corporation |
Saponin adjuvant
|
|
NZ230747A
(en)
|
1988-09-30 |
1992-05-26 |
Bror Morein |
Immunomodulating matrix comprising a complex of at least one lipid and at least one saponin; certain glycosylated triterpenoid saponins derived from quillaja saponaria molina
|
|
RU1615918C
(ru)
|
1989-05-22 |
1995-07-09 |
Всероссийский научно-исследовательский институт защиты животных |
Адъювант
|
|
GB8921470D0
(en)
*
|
1989-09-22 |
1989-11-08 |
Peptide Technology Ltd |
Vaccines
|
|
ZA936095B
(en)
|
1992-08-21 |
1994-03-14 |
Univ Melbourne |
Cytokine applications.
|
|
US6764682B1
(en)
|
1994-06-16 |
2004-07-20 |
Aventis Pasteur Limited |
Adjuvant compositions containing more than one adjuvant
|
|
US7935675B1
(en)
|
1994-07-15 |
2011-05-03 |
University Of Iowa Research Foundation |
Immunostimulatory nucleic acid molecules
|
|
US6207646B1
(en)
|
1994-07-15 |
2001-03-27 |
University Of Iowa Research Foundation |
Immunostimulatory nucleic acid molecules
|
|
US6846489B1
(en)
|
1995-04-25 |
2005-01-25 |
Smithkline Beecham Biologicals S.A. |
Vaccines containing a saponin and a sterol
|
|
ZA978434B
(en)
*
|
1996-09-27 |
1998-03-26 |
Akzo Nobel Nv |
Inactivated vaccines.
|
|
ATE292980T1
(de)
|
1996-10-11 |
2005-04-15 |
Univ California |
Immunostimulierende oligonucleotidekonjugate
|
|
US20100267012A1
(en)
*
|
1997-11-04 |
2010-10-21 |
Bergeron Michel G |
Highly conserved genes and their use to generate probes and primers for detection of microorganisms
|
|
EP0855184A1
(en)
|
1997-01-23 |
1998-07-29 |
Grayson B. Dr. Lipford |
Pharmaceutical composition comprising a polynucleotide and an antigen especially for vaccination
|
|
WO1998037919A1
(en)
|
1997-02-28 |
1998-09-03 |
University Of Iowa Research Foundation |
USE OF NUCLEIC ACIDS CONTAINING UNMETHYLATED CpG DINUCLEOTIDE IN THE TREATMENT OF LPS-ASSOCIATED DISORDERS
|
|
DK1005368T3
(da)
|
1997-03-10 |
2010-01-04 |
Ottawa Hospital Res Inst |
Anvendelse af nukleinsyrer, der indeholder ikke-metyleret CpG dinukleotid i kombination med alun som hjælpestoffer
|
|
US6406705B1
(en)
|
1997-03-10 |
2002-06-18 |
University Of Iowa Research Foundation |
Use of nucleic acids containing unmethylated CpG dinucleotide as an adjuvant
|
|
CA2289253A1
(en)
|
1997-04-30 |
1998-11-05 |
Merieux Oravax |
Anti-helicobacter vaccine composition for use by the subdiaphragmatic systemic route, and combined mucosal/parenteral immunization method
|
|
AU733310C
(en)
|
1997-05-14 |
2001-11-29 |
University Of British Columbia, The |
High efficiency encapsulation of charged therapeutic agents in lipid vesicles
|
|
EP1003850B1
(en)
|
1997-06-06 |
2009-05-27 |
The Regents of the University of California |
Inhibitors of dna immunostimulatory sequence activity
|
|
JP2002514397A
(ja)
|
1998-05-14 |
2002-05-21 |
コーリー ファーマシューティカル ゲーエムベーハー |
ＣｐＧオリゴヌクレオチドを用いる造血調節の方法
|
|
SI1077722T1
(sl)
|
1998-05-22 |
2007-02-28 |
Ottawa Health Research Inst |
Metode in produkti za induciranje sluznicne imunosti
|
|
US20040247662A1
(en)
|
1998-06-25 |
2004-12-09 |
Dow Steven W. |
Systemic immune activation method using nucleic acid-lipid complexes
|
|
PT1104306E
(pt)
|
1998-08-10 |
2006-05-31 |
Antigenics Inc |
Composicoes de cpg e adjuvantes de saponina e seus metodos
|
|
AUPP807399A0
(en)
|
1999-01-08 |
1999-02-04 |
Csl Limited |
Improved immunogenic lhrh composition and methods relating thereto
|
|
EP1156781B1
(en)
|
1999-02-26 |
2005-06-08 |
Chiron Corporation |
Microemulsions with adsorbed macromolecules and microparticles
|
|
AU4188100A
(en)
|
1999-04-08 |
2000-11-14 |
Gregory M. Glenn |
Dry formulation for transcutaneous immunization
|
|
US6977245B2
(en)
|
1999-04-12 |
2005-12-20 |
The United States Of America As Represented By The Department Of Health And Human Services |
Oligodeoxynucleotide and its use to induce an immune response
|
|
PT1187629E
(pt)
|
1999-04-19 |
2005-02-28 |
Glaxosmithkline Biolog Sa |
Composicao adjuvante que compreende saponina e um oligonucleotido imunoestimulador
|
|
EP1177439B1
(en)
|
1999-04-29 |
2004-09-08 |
Coley Pharmaceutical GmbH |
Screening for immunostimulatory dna functional modifiers
|
|
AU2001227889A1
(en)
|
2000-01-14 |
2001-07-24 |
The United States of America, represented by The Secretary, Department of Health & Human Services |
Oligodeoxynucleotide and its use to induce an immune response
|
|
US20010044416A1
(en)
|
2000-01-20 |
2001-11-22 |
Mccluskie Michael J. |
Immunostimulatory nucleic acids for inducing a Th2 immune response
|
|
AT409085B
(de)
|
2000-01-28 |
2002-05-27 |
Cistem Biotechnologies Gmbh |
Pharmazeutische zusammensetzung zur immunmodulation und herstellung von vakzinen
|
|
JP5025871B2
(ja)
|
2000-02-21 |
2012-09-12 |
エイチ．リュンドベック エイ／エス |
アミロイドの新規なダウン−レギュレート方法
|
|
AU5736601A
(en)
|
2000-05-01 |
2001-11-12 |
Hybridon Inc |
Modulation of oligonucleotide cpg-mediated immune stimulation by positional modification of nucleosides
|
|
AT410173B
(de)
|
2000-06-08 |
2003-02-25 |
Cistem Biotechnologies Gmbh |
Antigene zusammensetzung
|
|
AU2002244337B2
(en)
*
|
2000-10-18 |
2005-08-11 |
Glaxosmithkline Biologicals S.A. |
Vaccines
|
|
GB0025577D0
(en)
|
2000-10-18 |
2000-12-06 |
Smithkline Beecham Biolog |
Vaccine
|
|
CA2881568C
(en)
*
|
2000-10-27 |
2019-09-24 |
Novartis Vaccines And Diagnostics, Inc. |
Nucleic acids and proteins from streptococcus groups a & b
|
|
ES2307568T3
(es)
|
2000-12-08 |
2008-12-01 |
Coley Pharmaceutical Gmbh |
Acidos nucleicos de tipo cpg y metodos de uso de los mismos.
|
|
US7244438B2
(en)
|
2001-01-05 |
2007-07-17 |
Intercell Ag |
Uses for polycationic compounds
|
|
US7713942B2
(en)
|
2001-04-04 |
2010-05-11 |
Nordic Vaccine Technology A/S |
Cage-like microparticle complexes comprising sterols and saponins for delivery of polynucleotides
|
|
CA2439111A1
(en)
|
2001-04-05 |
2002-10-17 |
Chiron Corporation |
Mucosal boosting following parenteral priming
|
|
US7105495B2
(en)
|
2001-04-30 |
2006-09-12 |
Idera Pharmaceuticals, Inc. |
Modulation of oligonucleotide CpG-mediated immune stimulation by positional modification of nucleosides
|
|
WO2002094845A2
(en)
|
2001-05-21 |
2002-11-28 |
Intercell Ag |
Method for stabilising of nucleic acids
|
|
EP1395262A4
(en)
|
2001-06-15 |
2006-04-12 |
Ribapharm Corp |
NUCLEOSIDE-VACCINE-ADJUVANTS
|
|
WO2003003941A2
(en)
|
2001-07-02 |
2003-01-16 |
Pfizer Products Inc. |
One dose vaccination with mycoplasma hyopneumoniae
|
|
WO2003004051A2
(en)
|
2001-07-02 |
2003-01-16 |
Pfizer Products Inc. |
Mycoplasma hyopneumoniae vaccine and methods for reducing mycoplasma bovis pneumonia in cattle
|
|
US7666674B2
(en)
|
2001-07-27 |
2010-02-23 |
The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services |
Use of sterically stabilized cationic liposomes to efficiently deliver CPG oligonucleotides in vivo
|
|
CA2456193A1
(en)
|
2001-08-03 |
2003-03-27 |
Medarex, Inc. |
Compositions comprising immunostimulatory oligonucleotides and uses thereof to enhance fc receptor-mediated immunotherapies
|
|
US20030133988A1
(en)
|
2001-08-07 |
2003-07-17 |
Fearon Karen L. |
Immunomodulatory compositions, formulations, and methods for use thereof
|
|
US20030138434A1
(en)
|
2001-08-13 |
2003-07-24 |
Campbell Robert L. |
Agents for enhancing the immune response
|
|
ATE411054T1
(de)
|
2001-08-17 |
2008-10-15 |
Coley Pharm Gmbh |
Kombinations-motif-immunstimulierende oligonukleotide mit verbesserter wirkung
|
|
IL159145A0
(en)
|
2001-08-28 |
2004-06-01 |
Pfizer Prod Inc |
Mycoplasma bovis challenge model, methods for administering m. bovis and methods for inducing pneumonic lung lesions
|
|
DE60234375D1
(de)
|
2001-09-14 |
2009-12-24 |
Cytos Biotechnology Ag |
VERPACKUNG VON IMMUNSTIMULIERENDEM CpG IN VIRUSÄHNLICHEN PARTIKELN: HERSTELLUNGSVERFAHREN UND VERWENDUNG
|
|
US20030119774A1
(en)
|
2001-09-25 |
2003-06-26 |
Marianna Foldvari |
Compositions and methods for stimulating an immune response
|
|
GB0123580D0
(en)
|
2001-10-01 |
2001-11-21 |
Glaxosmithkline Biolog Sa |
Vaccine
|
|
US20050238660A1
(en)
|
2001-10-06 |
2005-10-27 |
Babiuk Lorne A |
Cpg formulations and related methods
|
|
US7276489B2
(en)
|
2002-10-24 |
2007-10-02 |
Idera Pharmaceuticals, Inc. |
Modulation of immunostimulatory properties of oligonucleotide-based compounds by optimal presentation of 5′ ends
|
|
EP1441763A2
(en)
|
2001-11-07 |
2004-08-04 |
Inex Pharmaceuticals Corp. |
Mucosal adjuvants comprising an oligonucleotide and a cationic lipid
|
|
AU2002358616A1
(en)
|
2001-12-07 |
2003-06-17 |
Intercell Ag |
Immunostimulatory oligodeoxynucleotides
|
|
WO2003066649A1
(en)
|
2002-02-04 |
2003-08-14 |
Biomira Inc. |
Immunostimulatory, covalently lipidated oligonucleotides
|
|
US8088388B2
(en)
*
|
2002-02-14 |
2012-01-03 |
United Biomedical, Inc. |
Stabilized synthetic immunogen delivery system
|
|
EP1476456A4
(en)
|
2002-02-19 |
2007-06-20 |
Syntherica Corp |
COMPOSITIONS AND METHOD FOR SUBROGEN-ANTIBODY MODULATION OF AN IMMUNE RESPONSE AND TRANSPORT
|
|
EP3006043B1
(en)
|
2002-04-04 |
2019-05-29 |
Zoetis Belgium S.A. |
Immunostimulatory g,u-containing oligoribonucleotides
|
|
WO2003089590A2
(en)
|
2002-04-16 |
2003-10-30 |
Vaxin, Inc. |
TRANSIENT AND/OR PERMANENT MODIFICATION OF SEXUAL BEHAVIOR AND/OR FERTILITY USING RECOMBINANT CHIMERIC GnRH
|
|
KR101092043B1
(ko)
|
2002-04-22 |
2011-12-12 |
바이오니취 라이프 사이언시즈 인코포레이티드 |
올리고뉴클레오티드 조성물 및 면역 반응 조절시 이의 용도
|
|
KR100456681B1
(ko)
|
2002-05-22 |
2004-11-10 |
주식회사 대웅 |
박테리아의 염색체 ｄｎａ 파쇄물과 비독성리포폴리사카라이드를 포함하는 면역강화 및 조절 조성물
|
|
CA2487452A1
(en)
|
2002-05-28 |
2003-12-04 |
Robinson Ramirez-Pineda |
A method for generating antigen-presenting cells
|
|
CA2388049A1
(en)
|
2002-05-30 |
2003-11-30 |
Immunotech S.A. |
Immunostimulatory oligonucleotides and uses thereof
|
|
US20040009949A1
(en)
|
2002-06-05 |
2004-01-15 |
Coley Pharmaceutical Group, Inc. |
Method for treating autoimmune or inflammatory diseases with combinations of inhibitory oligonucleotides and small molecule antagonists of immunostimulatory CpG nucleic acids
|
|
SE0201701D0
(sv)
|
2002-06-05 |
2002-06-05 |
Gotovax Ab |
Treatment of epithelial tumors and infections
|
|
EP1575504A4
(en)
|
2002-08-01 |
2009-11-04 |
Us Gov Health & Human Serv |
METHOD FOR THE TREATMENT OF INFLAMMATORY ARTHROPATHIES WITH SUPPRESSORS OF THE CPG OLIGONUCLEOTIDES
|
|
TWI314134B
(en)
|
2002-11-05 |
2009-09-01 |
James Hardie Int Finance Bv |
Calcium silicate hydrate and the method for producing the same
|
|
MXPA05008051A
(es)
|
2003-01-29 |
2005-09-21 |
Pfizer Prod Inc |
Vacunas caninas contra bordetella bronchiseptica.
|
|
TWI350174B
(en)
*
|
2003-03-12 |
2011-10-11 |
Wyeth Corp |
Adjuvanted bovine vaccines
|
|
AU2004224761A1
(en)
|
2003-03-26 |
2004-10-07 |
Cytos Biotechnology Ag |
HIV-peptide-carrier-conjugates
|
|
AU2004226591B2
(en)
|
2003-04-04 |
2009-06-04 |
Zoetis Services Llc |
Microfluidized oil-in-water emulsions and vaccine compositions
|
|
SE0301998D0
(sv)
|
2003-07-07 |
2003-07-07 |
Isconova Ab |
Quil A fraction with low toxicity and use thereof
|
|
KR20110132416A
(ko)
|
2004-04-05 |
2011-12-07 |
화이자 프로덕츠 인코포레이티드 |
미세유체화된 수중유 유화액 및 백신 조성물
|
|
US7749520B2
(en)
|
2004-07-07 |
2010-07-06 |
Statens Serum Institut |
Compositions and methods for stabilizing lipid based adjuvant formulations using glycolipids
|
|
JP4987704B2
(ja)
*
|
2004-07-07 |
2012-07-25 |
スタテンス セールム インスティトゥート |
糖脂質を用いた、脂質系アジュバント製剤を安定化する組成物及び方法
|
|
WO2006106424A2
(en)
|
2005-04-07 |
2006-10-12 |
Pharmacia & Upjohn Company Llc |
Formulations and process for production of bordetella bronchiseptica p68 antigen and vaccines
|
|
CA2634888C
(en)
|
2006-01-26 |
2016-06-21 |
Pfizer Products Inc. |
Novel glycolipid adjuvant compositions
|
|
WO2007125940A1
(ja)
*
|
2006-04-25 |
2007-11-08 |
Kyowa Hakko Kogyo Co., Ltd. |
ネコノミ成虫由来ポリペプチド
|
|
PT2078080E
(pt)
*
|
2006-09-27 |
2015-09-18 |
Coley Pharm Gmbh |
Análogos dos oligonucleotídeos cpg que contêm análogos t hidrofóbicos com atividade imunoestimulante potenciada
|
|
US20080292663A1
(en)
|
2007-05-22 |
2008-11-27 |
Gerber Jay D |
Adjuvant compositions and methods for delivering vaccines
|
|
CL2008001806A1
(es)
*
|
2007-06-20 |
2008-09-05 |
Wyeth Corp |
Composicion de vacuna en emulsion agua en aceite que comprende un antigeno y un adyuvante en la fase acuosa; y metodo de elaboracion.
|
|
EP2023143A1
(en)
*
|
2007-08-06 |
2009-02-11 |
Boehringer Ingelheim Vetmedica Gmbh |
Immunogenic streptococcus proteins
|
|
US8703153B2
(en)
*
|
2008-06-16 |
2014-04-22 |
Prokarium Ltd. |
Salmonella vectored vaccines against Chlamydia and methods of use
|
|
ES2569907T3
(es)
*
|
2008-06-27 |
2016-05-13 |
Zoetis Services Llc |
Composiciones adyuvantes novedosas
|
|
GB0818231D0
(en)
*
|
2008-10-06 |
2008-11-12 |
Univ Nottingham |
Composition
|
|
CN101721698B
(zh)
|
2008-10-24 |
2014-04-02 |
法罗斯疫苗公司 |
抗口蹄疫疫苗组合物及其制备和应用
|
|
CA2753567C
(en)
|
2009-02-27 |
2019-12-31 |
Toray Industries, Inc. |
Immunogenic antigen-adjuvant microparticle complex
|
|
JP2013525271A
(ja)
*
|
2010-03-12 |
2013-06-20 |
チルドレンズ メディカル センター コーポレーション |
免疫原およびそのスクリーニング方法
|
|
EP2575878B1
(en)
*
|
2010-05-28 |
2018-06-13 |
Zoetis Belgium S.A. |
Vaccines comprising cholesterol and cpg as sole adjuvant-carrier molecules
|
|
US8765141B2
(en)
*
|
2010-07-01 |
2014-07-01 |
The United States Of America, As Represented By The Secretary Of Agriculture |
Development of a marker foot and mouth disease virus vaccine candidate that is attenuated in the natural host
|
|
CN101954080B
(zh)
|
2010-09-21 |
2013-11-06 |
中国农业科学院兰州兽医研究所 |
一种猪口蹄疫苗用的复合分子型佐剂及其制造方法
|
|
PL2670432T3
(pl)
|
2011-02-04 |
2021-10-11 |
Zoetis Services Llc |
Kompozycje immunogenne Bordetella bronchiseptica
|
|
EP2707025B8
(en)
*
|
2011-05-13 |
2017-08-23 |
Zoetis Services LLC |
Hendra and nipah virus g glycoprotein immunogenic compositions
|
|
US20130309273A1
(en)
|
2012-05-17 |
2013-11-21 |
Kimberly Hassett |
Thermostable Vaccine Compositions and Methods of Preparing Same
|
|
GB201111183D0
(en)
|
2011-06-30 |
2011-08-17 |
Animal Health Inst |
Peptide
|
|
MX382968B
(es)
*
|
2012-11-16 |
2025-03-12 |
United Biomedical Inc |
Vacuna de emergencia basada en péptidos sintéticos contra la fiebre aftosa.
|
|
CN103083663B
(zh)
|
2013-02-04 |
2014-12-10 |
江苏省农业科学院 |
一种免疫增强剂、灭活疫苗及其制备方法
|
|
BR112015021755A2
(pt)
*
|
2013-03-07 |
2017-07-18 |
Kane Biotech Inc |
composições antimicrobianas e antibiofilmes e métodos de aplicação das mesmas
|
|
US10357470B2
(en)
*
|
2013-03-07 |
2019-07-23 |
Kane Biotech Inc. |
Antimicrobial-antibiofilm compositions and methods of use thereof
|
|
CN105209067A
(zh)
|
2013-03-26 |
2015-12-30 |
皮尔布赖特研究所 |
稳定的fmdv衣壳
|
|
HK1224177A1
(zh)
*
|
2013-09-05 |
2017-08-18 |
硕腾服务有限责任公司 |
Hendra和nipah病毒g糖蛋白免疫原性組合物
|
|
UA130246C2
(uk)
*
|
2013-09-19 |
2025-12-31 |
Зоетіс Сервісіз Ллс |
Ад'ювант на основі олії
|
|
CN104013955B
(zh)
*
|
2014-06-18 |
2016-02-24 |
中国科学院过程工程研究所 |
一种不含表面活性剂的水包油乳液及其用途
|
|
RU2593718C1
(ru)
|
2015-03-16 |
2016-08-10 |
Федеральное государственное бюджетное учреждение "Федеральный центр охраны здоровья животных" (ФГБУ "ВНИИЗЖ") |
Вакцина инактивированная эмульсионная против ящура типов а, о, азия-1
|